Workflow
Rezolute(RZLT)
icon
Search documents
Rezolute(RZLT) - 2020 Q2 - Quarterly Report
2020-02-12 21:17
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54495 REZOLUTE, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 27-3440894 201 Redwood Shores Parkway, Suite 315, ...
Rezolute(RZLT) - 2020 Q1 - Quarterly Report
2019-11-14 20:27
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54495 REZOLUTE, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 27-3440894 (State of other jurisdiction of incorp ...
Rezolute (RZLT) Investor Presentation - Slideshow
2019-10-23 19:58
REZOLUT | --- | --- | --- | --- | |---------------------------------------------------------------------|-------|-------------------|-------| | | | | | | Corporate | | | | | Presentation | | | | | 4Q 2019 | | | | | TRANSFORMATIVE THERAPIES TARGETING RARE AND METABOLIC DISEASES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Copyright 2019. 1 | | Forward-Looking Statements Statements in this presentation that are not descriptions of historical facts are forward-looking statements relating to ...
Rezolute(RZLT) - 2019 Q4 - Annual Report
2019-09-10 00:51
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2019 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number 000-54495 REZOLUTE, INC. (Exact Name of Company as Specified in its Charter) Delaware 27-3440894 (State or other jurisdiction of incorporation o ...
Rezolute(RZLT) - 2019 Q3 - Quarterly Report
2019-05-10 18:21
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 17(a)(2)(B) of the Securities Act. ¨ Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) ¨ Yes x No Securities registered pursuant to Section 12(b) of the A ...
Rezolute(RZLT) - 2019 Q2 - Quarterly Report
2019-02-14 19:04
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54495 REZOLUTE, INC (Exact Name of Registrant as Specified in its Charter) Delaware 27-3440894 (State of other jurisdiction of incorpor ...